Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is It Too Late to Buy Vertex Pharmaceuticals Stock?


Investors love to see shares of the companies they own beating the market over, say, 10 years or more. But when that happens, there is always the worry that a corporation doesn't have much left in its growth tank.

Take Vertex Pharmaceuticals (NASDAQ: VRTX), a biotech that has delivered market-beating returns over the past decade. The drugmaker is still at it even amid the market downturn and currently sits near its 52-week high. Vertex has certainly been impressive, but are the company's best days already in the rearview mirror? Let's find out. 

VRTX Chart

Continue reading


Source Fool.com

Like: 0
Share

Comments